Incidents
González de Galdeano, I positive 12/07/2002 Positive test ID 212
González de Galdeano held a Therapeutic Use Exemption for the product, testing positive for it after Stage 6 of the 2002 Tour de France but being allowed to continue provided that he submit to further testing.
Teams and people
Products
Sources
- Galdeano exceeds limit for asthma medicine, but allowed to start, Cyclingnews.com, 17/07/2002